{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:32:34Z","timestamp":1760189554764,"version":"build-2065373602"},"reference-count":64,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.hoc.2016.11.004","type":"journal-article","created":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T16:52:05Z","timestamp":1490287925000},"page":"285-295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Uncommon Variants of T-Cell Lymphomas"],"prefix":"10.1016","volume":"31","author":[{"given":"Neha","family":"Mehta-Shah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Horwitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.hoc.2016.11.004_bib1","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2016.11.004_bib2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1182\/blood-2011-02-335216","article-title":"Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project","volume":"118","author":"Delabie","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2016.11.004_bib3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/his.12596","article-title":"Recent advances in intestinal lymphomas","volume":"66","author":"Foukas","year":"2015","journal-title":"Histopathology"},{"issue":"8","key":"10.1016\/j.hoc.2016.11.004_bib4","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1097\/PAS.0b013e31822067d1","article-title":"Nonhepatosplenic gammadelta T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation","volume":"35","author":"Garcia-Herrera","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.hoc.2016.11.004_bib5","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1182\/blood-2011-10-385559","article-title":"How I treat enteropathy-associated T-cell lymphoma","volume":"119","author":"Di Sabatino","year":"2012","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.hoc.2016.11.004_bib6","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/ajg.2012.219","article-title":"The prevalence of celiac disease in the United States","volume":"107","author":"Rubio-Tapia","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.hoc.2016.11.004_bib7","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1053\/j.gastro.2007.03.036","article-title":"Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes","volume":"132","author":"Deleeuw","year":"2007","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.hoc.2016.11.004_bib8","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1097\/PAS.0b013e318222dfcd","article-title":"Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent \u03b3\u03b4 T-cell receptor expression","volume":"35","author":"Chan","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.hoc.2016.11.004_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0198-8859(94)00130-I","article-title":"HLA-DRB, -DQA, and -DQB polymorphism in celiac disease and enteropathy-associated T-cell lymphoma. Common features and additional risk factors for malignancy","volume":"43","author":"Howell","year":"1995","journal-title":"Hum Immunol"},{"issue":"6","key":"10.1016\/j.hoc.2016.11.004_bib10","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/leu.2016.13","article-title":"JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma","volume":"30","author":"Nairismagi","year":"2016","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.hoc.2016.11.004_bib11","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1200\/JCO.2000.18.4.795","article-title":"Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center","volume":"18","author":"Gale","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.hoc.2016.11.004_bib12","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/leu.2013.41","article-title":"Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8alphaalpha phenotype","volume":"27","author":"Tan","year":"2013","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.hoc.2016.11.004_bib13","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/ajh.23213","article-title":"Type II enteropathy-associated T-cell lymphoma: a multicenter analysis from the Asia Lymphoma Study Group","volume":"87","author":"Tse","year":"2012","journal-title":"Am J Hematol"},{"issue":"18","key":"10.1016\/j.hoc.2016.11.004_bib14","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2009-07-231324","article-title":"Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation","volume":"115","author":"Sieniawski","year":"2010","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.hoc.2016.11.004_bib15","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1182\/blood-2012-11-466839","article-title":"Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT","volume":"121","author":"Jantunen","year":"2013","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.hoc.2016.11.004_bib16","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1182\/blood-2013-07-512830","article-title":"Indolent T-cell lymphoproliferative disease of the gastrointestinal tract","volume":"122","author":"Perry","year":"2013","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.hoc.2016.11.004_bib17","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.hoc.2008.07.010","article-title":"Peripheral T-cell non-Hodgkin's lymphoma","volume":"22","author":"Vose","year":"2008","journal-title":"Hematol Oncol Clin North Am"},{"year":"2008","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","key":"10.1016\/j.hoc.2016.11.004_bib18"},{"issue":"11","key":"10.1016\/j.hoc.2016.11.004_bib19","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1182\/blood.V75.11.2213.2213","article-title":"Hepatosplenic T-cell lymphoma: sinusal\/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta","volume":"75","author":"Farcet","year":"1990","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2016.11.004_bib20","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1172\/JCI115044","article-title":"Recombinative events of the T\u00a0cell antigen receptor delta gene in peripheral T\u00a0cell lymphomas","volume":"87","author":"Kanavaros","year":"1991","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.hoc.2016.11.004_bib21","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/bjc.2013.294","article-title":"Risk of lymphoma subtypes after solid organ transplantation in the United States","volume":"109","author":"Clarke","year":"2013","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.hoc.2016.11.004_bib22","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1097\/MIB.0b013e3182807618","article-title":"Do inflammatory bowel disease therapies cause cancer?","volume":"19","author":"Mason","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"13","key":"10.1016\/j.hoc.2016.11.004_bib23","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood-2003-05-1675","article-title":"Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients","volume":"102","author":"Belhadj","year":"2003","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2016.11.004_bib24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.clml.2012.09.002","article-title":"Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience","volume":"13","author":"Voss","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"6","key":"10.1016\/j.hoc.2016.11.004_bib25","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/annonc\/mdn751","article-title":"Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment","volume":"20","author":"Falchook","year":"2009","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.hoc.2016.11.004_bib26","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/leu.2014.280","article-title":"Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party","volume":"29","author":"Tanase","year":"2015","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.hoc.2016.11.004_bib27","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1038\/leu.2013.150","article-title":"Understanding the interplay between the proteasome pathway and autophagy in response to dual PI3K\/mTOR inhibition in myeloma cells is essential for their effective clinical application","volume":"27","author":"Aronson","year":"2013","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.hoc.2016.11.004_bib28","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1016\/j.clml.2013.12.017","article-title":"Lymphoma with features intermediate between aggressive T-large granular lymphocytic leukemia and hepatosplenic T-cell lymphoma: a diagnostic dilemma?","volume":"14","author":"Ok","year":"2014","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"4","key":"10.1016\/j.hoc.2016.11.004_bib29","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.det.2008.05.008","article-title":"Subcutaneous panniculitic-like T-cell lymphoma and other primary cutaneous lymphomas with prominent subcutaneous tissue involvement","volume":"26","author":"Gallardo","year":"2008","journal-title":"Dermatol Clin"},{"issue":"2","key":"10.1016\/j.hoc.2016.11.004_bib30","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.humpath.2003.09.015","article-title":"Clinicopathologic differences between 22 cases of CD56-negative and CD56-positive subcutaneous panniculitis-like lymphoma in Japan","volume":"35","author":"Takeshita","year":"2004","journal-title":"Hum Pathol"},{"issue":"11","key":"10.1016\/j.hoc.2016.11.004_bib31","first-page":"1372","article-title":"Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II","volume":"89","author":"Paulli","year":"2004","journal-title":"Haematologica"},{"issue":"Suppl 6","key":"10.1016\/j.hoc.2016.11.004_bib32","doi-asserted-by":"crossref","first-page":"vi149","DOI":"10.1093\/annonc\/mdt242","article-title":"Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Willemze","year":"2013","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.hoc.2016.11.004_bib33","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/cncr.20502","article-title":"Immunophenotypic and molecular features, clinical outcomes, treatments, and prognostic factors associated with subcutaneous panniculitis-like T-cell lymphoma: a systematic analysis of 156 patients reported in the literature","volume":"101","author":"Go","year":"2004","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.hoc.2016.11.004_bib34","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/00000421-199412000-00003","article-title":"Successful treatment of cytophagic histiocytic panniculitis with modified CHOP-E. Cyclophosphamide, adriamycin, vincristine, predonisone, and etoposide","volume":"17","author":"Matsue","year":"1994","journal-title":"Am J Clin Oncol"},{"issue":"12","key":"10.1016\/j.hoc.2016.11.004_bib35","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/sj.bmt.1705527","article-title":"Complete remission of subcutaneous panniculitic T-cell lymphoma after allogeneic transplantation","volume":"38","author":"Perez-Persona","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.hoc.2016.11.004_bib36","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1080\/10428190600783619","article-title":"Successful treatment of refractory subcutaneous panniculitis-like T-cell lymphoma with allogeneic peripheral blood stem cell transplantation from HLA-mismatched sibling donor","volume":"47","author":"Ichii","year":"2006","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.hoc.2016.11.004_bib37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.12659\/AOT.882007","article-title":"Durable remission in a patient with refractory subcutaneous panniculitis-like T-cell lymphoma relapse after allogeneic hematopoietic stem cell transplantation through withdrawal of cyclosporine","volume":"16","author":"Yuan","year":"2011","journal-title":"Ann Transplant"},{"issue":"6","key":"10.1016\/j.hoc.2016.11.004_bib38","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1034\/j.1600-0609.2003.00058.x","article-title":"Successful treatment of a patient with subcutaneous panniculitis-like T-cell lymphoma with high-dose chemotherapy and total body irradiation","volume":"70","author":"Mukai","year":"2003","journal-title":"Eur J Haematol"},{"issue":"1","key":"10.1016\/j.hoc.2016.11.004_bib39","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.clml.2011.06.016","article-title":"Bexarotene is active against subcutaneous panniculitis-like T-cell lymphoma in adult and pediatric populations","volume":"12","author":"Mehta","year":"2012","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"1","key":"10.1016\/j.hoc.2016.11.004_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-4362.1996.tb01606.x","article-title":"Subcutaneous panniculitic T-cell lymphoma","volume":"35","author":"Wang","year":"1996","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1016\/j.hoc.2016.11.004_bib41","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3816\/CLM.2002.n.024","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: presentation of 2 cases and observations","volume":"3","author":"Papenfuss","year":"2002","journal-title":"Clin Lymphoma"},{"issue":"3","key":"10.1016\/j.hoc.2016.11.004_bib42","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.annder.2008.07.061","article-title":"Two cases of subcutaneous panniculitis-like T-cell lymphoma (CD4- CD8+ CD56-)","volume":"136","author":"Springinsfeld","year":"2009","journal-title":"Ann Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.hoc.2016.11.004_bib43","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4143\/crt.2011.43.4.255","article-title":"Cyclosporine in relapsed subcutaneous panniculitis-like T-cell lymphoma after autologous hematopoietic stem cell transplantation","volume":"43","author":"Jung","year":"2011","journal-title":"Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.hoc.2016.11.004_bib44","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4143\/crt.2014.46.3.312","article-title":"Cyclosporine a as a primary treatment for panniculitis-like T\u00a0cell lymphoma: a case with a long-term remission","volume":"46","author":"Lee","year":"2014","journal-title":"Cancer Res Treat"},{"issue":"8","key":"10.1016\/j.hoc.2016.11.004_bib45","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3816\/CLM.2007.n.040","article-title":"Efficacy of denileukin diftitox in subcutaneous panniculitis-like T-cell lymphoma","volume":"7","author":"Hathaway","year":"2007","journal-title":"Clin Lymphoma Myeloma"},{"issue":"11","key":"10.1016\/j.hoc.2016.11.004_bib46","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1097\/PAS.0b013e31826a5038","article-title":"Cutaneous gammadelta T-cell lymphomas: a spectrum of presentations with overlap with other cytotoxic lymphomas","volume":"36","author":"Guitart","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.hoc.2016.11.004_bib47","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1182\/blood-2002-05-1597","article-title":"Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma","volume":"101","author":"Toro","year":"2003","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.hoc.2016.11.004_bib48","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/cas.12439","article-title":"Clinicopathological analysis of 17 primary cutaneous T-cell lymphoma of the gammadelta phenotype from Japan","volume":"105","author":"Takahashi","year":"2014","journal-title":"Cancer Sci"},{"issue":"1","key":"10.1016\/j.hoc.2016.11.004_bib49","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1309\/AJCPQGVLTZQ77VFF","article-title":"Indolent primary cutaneous gamma\/delta T-cell lymphoma localized to the subcutaneous panniculus and its association with atypical lymphocytic lobular panniculitis","volume":"138","author":"Magro","year":"2012","journal-title":"Am J Clin Pathol"},{"issue":"18","key":"10.1016\/j.hoc.2016.11.004_bib50","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1182\/blood-2013-05-502203","article-title":"Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma","volume":"122","author":"Quintanilla-Martinez","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2016.11.004_bib51","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jaad.2013.01.037","article-title":"Hydroa vacciniforme-like cutaneous T-cell lymphoma: clinicopathologic and immunohistochemical study of 12 cases","volume":"69","author":"Sangueza","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.hoc.2016.11.004_bib52","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","article-title":"EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases","volume":"119","author":"Kimura","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2016.11.004_bib53","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/10428194.2016.1179297","article-title":"Clinicopathological categorization of Epstein-Barr virus-positive T\/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications","volume":"58","author":"Paik","year":"2017","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.hoc.2016.11.004_bib54","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/01.pap.0000151318.34752.80","article-title":"The pathology of NK-cell lymphomas and leukemias","volume":"12","author":"Nava","year":"2005","journal-title":"Adv Anat Pathol"},{"issue":"1","key":"10.1016\/j.hoc.2016.11.004_bib55","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0560.2009.01278.x","article-title":"Indolent CD8+ lymphoid proliferation of the ear: a phenotypic variant of the small-medium pleomorphic cutaneous T-cell lymphoma?","volume":"37","author":"Beltraminelli","year":"2010","journal-title":"J\u00a0Cutan Pathol"},{"issue":"4","key":"10.1016\/j.hoc.2016.11.004_bib56","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3109\/10428194.2014.938331","article-title":"CD4+ primary cutaneous small\/medium-sized pleomorphic T-cell lymphoma: a retrospective case series and review of literature","volume":"56","author":"James","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.hoc.2016.11.004_bib57","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/PAS.0b013e31818e52fe","article-title":"Primary cutaneous CD4+ small\/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers","volume":"33","author":"Rodriguez Pinilla","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.hoc.2016.11.004_bib58","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/DAD.0b013e31819f19bb","article-title":"Primary cutaneous CD4+ small-\/medium-sized pleomorphic T-cell lymphoma: a cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance? A study of 136 cases","volume":"31","author":"Beltraminelli","year":"2009","journal-title":"Am J Dermatopathol"},{"issue":"2","key":"10.1016\/j.hoc.2016.11.004_bib59","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1600-0560.2010.01647.x","article-title":"Indolent CD8+ lymphoid proliferation of the ear: report of two cases and review of the literature","volume":"38","author":"Swick","year":"2011","journal-title":"J\u00a0Cutan Pathol"},{"issue":"6","key":"10.1016\/j.hoc.2016.11.004_bib60","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1182\/blood-2002-07-1960","article-title":"Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients","volume":"102","author":"Bekkenk","year":"2003","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.hoc.2016.11.004_bib61","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/modpathol.2008.40","article-title":"Primary cutaneous CD4-positive small\/medium-sized pleomorphic T-cell lymphoma: a clonal T-cell lymphoproliferative disorder with indolent behavior","volume":"21","author":"Grogg","year":"2008","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.hoc.2016.11.004_bib62","first-page":"389","article-title":"Primary cutaneous small- to medium-sized CD4+ pleomorphic T-cell lymphoma: a retrospective case series and review of the provisional cutaneous lymphoma category","volume":"12","author":"Williams","year":"2011","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"10.1016\/j.hoc.2016.11.004_bib63","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jaad.2010.07.028","article-title":"Reappraisal of the provisional entity primary cutaneous CD4+ small\/medium pleomorphic T-cell lymphoma: a series of 10 adult and pediatric patients and review of the literature","volume":"65","author":"Baum","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.hoc.2016.11.004_bib64","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1600-0560.2009.01448.x","article-title":"Indolent CD8-positive lymphoid proliferation on the face: part of the spectrum of primary cutaneous small-\/medium-sized pleomorphic T-cell lymphoma or a distinct entity?","volume":"37","author":"Suchak","year":"2010","journal-title":"J\u00a0Cutan Pathol"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858816301721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858816301721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:04:11Z","timestamp":1760184251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858816301721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0889858816301721"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2016.11.004","relation":{},"ISSN":["0889-8588"],"issn-type":[{"type":"print","value":"0889-8588"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uncommon Variants of T-Cell Lymphomas","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2016.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}